Browse by author
Lookup NU author(s): Dr Paul Mackin, Professor Allan Young
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background: Antipsychotic drugs have been associated with prolongation of the QTc interval on the electrocardiogram, and QTc prolongation is, in turn, associated with an increased risk of cardiac arrhythmias and sudden death. Antipsychotic polypharmacy has been implicated in reduced survival, possibly secondary to cardiotoxic effects of antipsychotic medication. Abnormalities of glucose homeostasis, which may be more common in individuals with major mood disorders and schizophrenia, also affect the QTc interval. Method: We performed detailed assessment of metabolic parameters in 103 psychiatric outpatients, from across the diagnostic spectrum, who had been taking antipsychotic medication (typical, atypical, or a combination thereof) for a minimum of 6 months. We measured the QTc interval in a subset of these patients (N = 65). Results: Only 2 patients (3%) had a prolonged QTc interval. There was a statistical trend (p = .08) toward a lower QTc interval in patients receiving antipsychotic polypharmacy. QTc interval was associated with age (p = .04) but not with any metabolic parameter. Conclusion: QTc prolongation in this population is uncommon. There was a significant association between increasing age and QTc interval, but cardiac repolarization was not related to any metabolic parameter. Further large prospective studies of similar patients are needed to confirm these findings.
Author(s): Mackin P, Young AH
Publication type: Article
Publication status: Published
Journal: Journal of Clinical Psychiatry
Year: 2005
Volume: 66
Issue: 11
Pages: 1386-1391
ISSN (print): 0160-6689
ISSN (electronic): 1555-2101
Publisher: Physicians Postgraduate Press, Inc.
URL: http://dx.doi.org/10.4088/JCP.v66n1107
DOI: 10.4088/JCP.v66n1107
PubMed id: 16420075
Altmetrics provided by Altmetric
